As expected, significantly more patients with SLE were ANA reactive as assessed by immunoblot analysis of ANA subtype reactivity, compared with the controls diagnosed negative for any connective tissue or allergic disease by clinical history and examination. This evidence concerns the gene BTG3 and allergic disease.